Looking for markers of blood vessel damage in preeclampsia
Part of Women’s health & pregnancy clinical trials.
This trial is looking for women with preeclampsia to help find markers in the blood that show how blood vessels are affected. The goal is to better understand the condition and possibly improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have preeclampsia (or be suspected of having it).
- You must be willing to have tests to check your blood vessels.
- You cannot have certain health conditions like glaucoma, epilepsy, diabetes (including gestational diabetes), high cholesterol, kidney disease, autoimmune disorders, or connective tissue diseases.
- You must not be pregnant with more than one baby or have a baby with known birth defects.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well your blood vessels work during pregnancy to help predict high blood pressure disorders. If you join, you will have extra monitoring and blood tests.
This study looks at tiny particles released from blood vessels in pregnant women with high blood pressure. The goal is to find better ways to detect and manage conditions like preeclampsia.
This study collects samples from pregnant people with preeclampsia (a serious pregnancy blood-pressure condition) and from healthy pregnancy controls. Researchers will study tiny particles (“exosomes”) to see how they differ and whether these signals could help explain or improve care for preeclampsia.
This study tests if certain blood markers can help diagnose and monitor preeclampsia. It aims to improve how this serious pregnancy condition is detected and treated.
This study looks at how the heart and blood vessels work after a pregnancy complicated by preeclampsia. It uses exercise testing to see if there are lasting effects, which may help improve long-term heart health monitoring and care.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
Hear when a new Endothelial Function (FMD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.